Ryvu Therapeutics S.A.
RVU.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -PLN 111 | -PLN 92 | -PLN 84 | -PLN 78 |
| Dep. & Amort. | PLN 10 | PLN 11 | PLN 13 | PLN 13 |
| Deferred Tax | PLN 0 | PLN 0 | -PLN 22 | -PLN 23 |
| Stock-Based Comp. | PLN 0 | PLN 0 | PLN 22 | PLN 23 |
| Change in WC | -PLN 16 | -PLN 14 | PLN 66 | -PLN 15 |
| Other Non-Cash | -PLN 12 | PLN 11 | PLN 26 | PLN 22 |
| Operating Cash Flow | -PLN 129 | -PLN 85 | PLN 21 | -PLN 58 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -PLN 6 | -PLN 9 | -PLN 9 | -PLN 12 |
| Net Acquisitions | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Inv. Purchases | PLN 0 | -PLN 193 | -PLN 1 | -PLN 5 |
| Inv. Sales/Matur. | PLN 0 | PLN 0 | PLN 5 | PLN 25 |
| Other Inv. Act. | PLN 143 | PLN 6 | PLN 6 | PLN 0 |
| Investing Cash Flow | PLN 137 | -PLN 196 | PLN 1 | PLN 8 |
| Financing Activities | – | – | – | – |
| Debt Repay. | PLN 95 | -PLN 1 | -PLN 1 | -PLN 1 |
| Stock Issued | PLN 0 | PLN 250 | PLN 0 | PLN 0 |
| Stock Repurch. | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Dividends Paid | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Other Fin. Act. | -PLN 0 | -PLN 9 | -PLN 2 | -PLN 3 |
| Financing Cash Flow | PLN 94 | PLN 241 | -PLN 2 | -PLN 3 |
| Forex Effect | PLN 0 | -PLN 5 | -PLN 1 | PLN 0 |
| Net Chg. in Cash | PLN 102 | -PLN 44 | PLN 19 | -PLN 53 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | PLN 58 | PLN 102 | PLN 83 | PLN 136 |
| End Cash | PLN 160 | PLN 58 | PLN 102 | PLN 83 |
| Free Cash Flow | -PLN 135 | -PLN 88 | PLN 12 | -PLN 70 |